Evidence map›Paper›PMID 25460228›Full record

ReviewCurrent opinion in pharmacology2014

Transgenerational effects of obesogens and the obesity epidemic.

Raquel Chamorro-García, Bruce Blumberg

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in pharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Obesogens in Foods.Biomolecules · 2022
    Review
  10. Male Infertility in the XXI Century: Are Obesogens to Blame?International journal of molecular sciences · 2022
    Review
  11. Review
  12. Article
  13. Adipose Tissue and Endocrine-Disrupting Chemicals: Does Sex Matter?International journal of environmental research and public health · 2020
    Review
  14. Agrochemicals and obesity.Molecular and cellular endocrinology · 2020
    Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Raquel Chamorro-GarcíaDepartment of Developmental and Cell Biology, 2011 Biological Sciences 3, Irvine, CA 92697-2300, USA.
Bruce Blumberg
University of California, Irvine · US

Funding

Transgenerational obesity caused by ancestral exposure to obesogens in utero: changes in germline genomic architecture, roles of gonadal somatic cells, and metabolomic analysis of sexual dimorphismR01ES023316 · NIEHS · UNIVERSITY OF CALIFORNIA-IRVINE · PI BRUCE BLUMBERG, TOSHIHIRO SHIODA · 2013 to 2026
$8.3M
Endocrine disruption by organotins in obesity and diabetesR01ES015849 · NIEHS · UNIVERSITY OF CALIFORNIA-IRVINE · PI BLUMBERG, BRUCE · 2007 to 2011
$2.2M
Is bisphenol A diglycidyl ether (BADGE) and obesogen?R21ES021020 · NIEHS · UNIVERSITY OF CALIFORNIA-IRVINE · PI BLUMBERG, BRUCE · 2012 to 2013
$407k
NIEHS NIH HHS 1R01ES023316NIEHS NIH HHS 1R21ES021020NIEHS NIH HHS R01 ES015849NIEHS NIH HHS R01 ES023316NIEHS NIH HHS R21 ES021020
6 · The paper itself

Abstract

In the last three decades there has been a dramatic, worldwide increase in the incidence of obesity, particularly in Western societies. This trend has required a significant economic investment to treat obesity-related disorders such as type 2 diabetes, cardiovascular disease, and non-alcoholic fatty liver disease. There is an urgent need to understand the factors that contribute to this increase in obesity in order to find new tools that will improve quality of life in affected individuals and to avoid the propagation of obesity to future generations. Endocrine disrupting chemicals have become an important piece of the obesity epidemic puzzle but little is known about the mechanism underlying their effects. In this commentary, we highlight recent work showing that the consequences of ancestral exposure to obesogenic chemicals results in the transmission of obesity-related phenotypes through at least three generations.

Indexed as

Prenatal Exposure Delayed EffectsAnimalsEndocrine DisruptorsEpidemicsEpigenesis, GeneticFemaleHumansObesityPregnancyEndocrine Disruptors

Identifiers

PMID25460228
PMCPMC4297575
OpenAlexW2143543251

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.